Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 6
1948 4
1949 3
1951 2
1952 1
1953 1
1957 1
1959 1
1960 4
1961 1
1962 1
1964 2
1965 5
1966 4
1967 2
1968 2
1969 2
1970 3
1971 3
1972 2
1973 1
1974 3
1975 5
1976 2
1977 2
1978 3
1979 2
1980 4
1981 8
1982 6
1983 3
1984 4
1985 4
1986 5
1987 4
1988 5
1989 2
1990 3
1991 2
1992 1
1993 3
1994 7
1995 4
1996 1
1997 9
1998 3
1999 5
2000 5
2001 10
2002 3
2003 3
2004 4
2005 5
2006 7
2007 7
2008 6
2009 15
2010 8
2011 10
2012 12
2013 10
2014 10
2015 12
2016 8
2017 10
2018 11
2019 6
2020 22
2021 16
2022 11
2023 7
2024 9
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric erythromelalgia from multidisciplinary perspectives: a scoping review.
Ocay DD, Graziano Maloney M, D'Souza G, Brownstein CA, Clinch J, Davis DM, De Ranieri D, Donado C, Halpin M, Kattail D, Lee BH, Lobo K, Ravetti D, Sandroni P, Stinson JN, Tham SW, Walco GA, Walker SM, Yu TW, Berde CB. Ocay DD, et al. Among authors: walker sm. Pediatr Res. 2025 Jan 16. doi: 10.1038/s41390-025-03817-4. Online ahead of print. Pediatr Res. 2025. PMID: 39821136 Review.
A randomised controlled feasibility trial of Behavioural activation as a treatment for people with diabetes and depression: (DiaDeM feasibility trial).
Ahmed N, Zavala GA, Siddiqui F, Aslam F, Keding A, Halmkan S, Afaq S, Jennings HM, Anas A, Shaha SK, Jahan KM, Kuddus A, Nisar Z, Walker SM, Naz A, Shakoor H, Niazi AK, Jacobs R, Coales K, Azad K, Fottrell E, Haq ZU, Ekers D, Siddiqi N, Hewitt C; DiaDeM Global Health Research Group. Ahmed N, et al. Among authors: walker sm. J Affect Disord. 2025 Mar 1;372:333-346. doi: 10.1016/j.jad.2024.11.079. Epub 2024 Dec 6. J Affect Disord. 2025. PMID: 39647587 Free article. Clinical Trial.
Illustrative Review of Nuclear Medicine Thyroid Studies.
Walker SM, Schneider A, Olulade O, Zabel T, Wakefield C, Auer B, Barletta JA, Marqusee E, Shah H. Walker SM, et al. Radiographics. 2024 Feb;44(2):e230095. doi: 10.1148/rg.230095. Radiographics. 2024. PMID: 38271256 No abstract available.
Deep-Sea Sponges and Corals off the Western Coast of Florida-Intracellular Mechanisms of Action of Bioactive Compounds and Technological Advances Supporting the Drug Discovery Pipeline.
Iskandar M, Ruiz-Houston KM, Bracco SD, Sharkasi SR, Calabi Villarroel CL, Desai MN, Gerges AG, Ortiz Lopez NA, Xiao Barbero M, German AA, Moluguri VS, Walker SM, Silva Higashi J, Palma JM, Medina DZ, Patel M, Patel P, Valentin M, Diaz AC, Karthaka JP, Santiago AD, Skiles RB, Romero Umana LA, Ungrey MD, Wojtkowiak A, Howard DV, Nurge R, Woods KG, Nanjundan M. Iskandar M, et al. Among authors: walker sm. Mar Drugs. 2023 Nov 28;21(12):615. doi: 10.3390/md21120615. Mar Drugs. 2023. PMID: 38132936 Free PMC article. Review.
STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.
Yin CC, Tam W, Walker SM, Kaur A, Ouseph MM, Xie W, K Weinberg O, Li P, Zuo Z, Routbort MJ, Chen S, Medeiros LJ, George TI, Orazi A, Arber DA, Bagg A, Hasserjian RP, Wang SA. Yin CC, et al. Among authors: walker sm. Haematologica. 2024 Jun 1;109(6):1825-1835. doi: 10.3324/haematol.2023.284311. Haematologica. 2024. PMID: 37981812 Free PMC article.
346 results